NewsBenzingaVivani Medical fait progresser son implant de sémaglutide à action prolongée vers un essai de phase 2 en 2027 Vivani Medical fait progresser son implant de sémaglutide à action prolongée vers un essai de phase 2 en 2027 Benzinga 2026.11.12 17:08 (GMT+0) Open on Benzinga Other news OpenAI CEO Sam Altman says it’s ‘hard to imagine the AI industry without Jensen’ Nvidia’s Jensen Huang Scandal Just Got More Expensive Billionaire Brad Gerstner Is Betting $5 Billion on the Anthropic IPO. The Smart Money Is Shrugging Off the AI Panic. Sony’s updated turntable is an easy entry into the world of vinyl As Tesla Plans to Roll Out the Cybercab for Individual Use, TSLA Stock Is a Tough Nut to Crack How the Anthropic IPO stacks up against SpaceX
Billionaire Brad Gerstner Is Betting $5 Billion on the Anthropic IPO. The Smart Money Is Shrugging Off the AI Panic.